Day: June 9, 2018

The study shows up in the February problem of GIE: Gastrointestinal Endoscopy.

The existing best, though imperfect, marker of neoplastic progression can be dysplasia detected in mucosal biopsy specimens of the lining of the esophagus obtained at the time of endoscopy. High-quality dysplasia is connected with a high rate of progression to invasive esophageal cancer. Detection and pathologic confirmation of early Become neoplasia is important because endoscopic therapy here is highly successful. Unfortunately, neoplasia in BE might not be evident with just endoscopic inspection even, so the current standard of care is normally endoscopic surveillance with high-quality white-light endoscopy using systematic 4-quadrant biopsies every 1 to 2 2 cm of BE size and targeted biopsies of any mucosal irregularities. Read More